About
About Medical Developments International Limited
Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory products, including space chambers, peak flow meters, portable nebulizers, and silicone face masks to aid sufferers of asthma and chronic obstructive pulmonary disease. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.
Visit company website
5 years, 5 months ago
Medical Developments International Limited is currently in a long term downtrend where the price is trading 23.3% below its 200 day moving average.
From a valuation standpoint, the stock is 94.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 14.7.
Medical Developments International Limited's total revenue rose by 13.3% to $13M since the same quarter in the previous year.
Its net income has dropped by 573.8% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 41.7% to $-2M since the same quarter in the previous year.
Based on the above factors, Medical Developments International Limited gets an overall score of 3/5.